Tysabri Webcast Citation May Signal That FDA Could Treat All Social Media Interactions As Promotional; Biogen's PML Strategy Also Takes A Hit
Executive Summary
FDA appears to be gearing up to treat social media interactions as promotional even when they are aimed solely at informing physicians